Byrnes Michael
CIK: 0001619893•Chief Financial Officer
Officer
Primary company: Ocera Therapeutics, Inc. (OCRX)
Byrnes Michael is a corporate insider (Chief Financial Officer) at Ocera Therapeutics, Inc. (OCRX) filing SEC Form 4 transactions. 34 transactions across 3 companies, totaling $63,007 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 9,326 | - | - | 9,326 | 5/30/2025 Filed: 6/2/2025 | Filing → | |
| Award | 17,923 | $1.43 | $26K | 17,923 | 3/4/2025 Filed: 3/6/2025 | Filing → | |
| Award | 127,500 | $0.10 | $13K | 255,000 | 2/24/2025 Filed: 2/26/2025 | Filing → | |
| Award | 127,500 | - | - | 127,500 | 12/2/2024 Filed: 12/4/2024 | Filing → | |
| Award | 1,387 | $1.68 | $2K | 3,117 | 5/15/2024 Filed: 5/17/2024 | Filing → | |
| Award | 112,500 | - | - | 112,500 | 3/25/2024 Filed: 3/27/2024 | Filing → | |
| Award | 40,000 | - | - | 40,000 | 2/19/2024 Filed: 2/21/2024 | Filing → | |
| Award | 4,524 | $0.50 | $2K | 43,271 | 11/15/2023 Filed: 11/16/2023 | Filing → | |
| Award | 4,863 | $0.46 | $2K | 38,747 | 5/15/2023 Filed: 5/16/2023 | Filing → | |
| Award | 500,000 | $0.00 | $0 | 500,000 | 1/17/2023 Filed: 1/19/2023 | Filing → | |
| Award | 4,651 | $0.47 | $2K | 33,884 | 11/15/2022 Filed: 11/16/2022 | Filing → | |
| Award | 235,541 | $0.00 | $0 | 235,541 | 6/20/2022 Filed: 6/22/2022 | Filing → | |
| Purchase | 25,000 | $1.33 | $33K | 29,233 | 6/7/2022 Filed: 6/7/2022 | Filing → | |
| Award | 4,233 | $1.53 | $6K | 4,233 | 5/13/2022 Filed: 5/17/2022 | Filing → | |
| Award | 235,541 | $0.00 | $0 | 235,541 | 1/20/2022 Filed: 1/24/2022 | Filing → | |
| Award | 49,790 | $0.00 | $0 | 49,790 | 8/25/2021 Filed: 8/27/2021 | Filing → | |
| Award | 337,997 | $0.00 | $0 | 337,997 | 8/25/2021 Filed: 8/27/2021 | Filing → | |
Ocera Therapeutics, Inc. OCRX | Disposition | 70,000 | - | - | 0 | 12/11/2017 Filed: 12/11/2017 | Filing → |
Ocera Therapeutics, Inc. OCRX | Disposition | 102,300 | - | - | 0 | 12/11/2017 Filed: 12/11/2017 | Filing → |
Ocera Therapeutics, Inc. OCRX | Disposition | 75,000 | - | - | 0 | 12/11/2017 Filed: 12/11/2017 | Filing → |
Type
Award
Shares
9,326
Price
-
Value
-
Type
Award
Shares
17,923
Price
$1.43
Value
$26K
Type
Award
Shares
127,500
Price
$0.10
Value
$13K
Type
Award
Shares
127,500
Price
-
Value
-
Type
Award
Shares
1,387
Price
$1.68
Value
$2K
Type
Award
Shares
112,500
Price
-
Value
-
Type
Award
Shares
40,000
Price
-
Value
-
Type
Award
Shares
4,524
Price
$0.50
Value
$2K
Type
Award
Shares
4,863
Price
$0.46
Value
$2K
Type
Award
Shares
500,000
Price
$0.00
Value
$0
Type
Award
Shares
4,651
Price
$0.47
Value
$2K
Type
Award
Shares
235,541
Price
$0.00
Value
$0
Type
Purchase
Shares
25,000
Price
$1.33
Value
$33K
Type
Award
Shares
4,233
Price
$1.53
Value
$6K
Type
Award
Shares
235,541
Price
$0.00
Value
$0
Type
Award
Shares
49,790
Price
$0.00
Value
$0
Type
Award
Shares
337,997
Price
$0.00
Value
$0
Ocera Therapeutics, Inc.
OCRX
Type
Disposition
Shares
70,000
Price
-
Value
-
Ocera Therapeutics, Inc.
OCRX
Type
Disposition
Shares
102,300
Price
-
Value
-
Ocera Therapeutics, Inc.
OCRX
Type
Disposition
Shares
75,000
Price
-
Value
-
AI Agent
Try asking...